Abstract:Cardiac surgery is associated with hyperglycemia, which in turn is associated with adverse post-surgical outcomes such as wound infections, acute renal failure, and mortality. This pilot study seeks to determine if Dexcom G6Pro continuous glucose monitor (Dexcom G6Pro CGM) is accurate during the postoperative cardiac surgery period when fluid shifts, systemic inflammatory response syndrome (SIRS), and vasoactive medications are frequently encountered, compared to standard glucose monitoring techniques. Methods This study received IRB approval. In this prospective study, correlation between clinical and Dexcom glucose readings was evaluated. Clinical glucose (blood gas, metabolic panel, and point of care [POC]) dataset included 1428 readings from 29 patients, while the Dexcom G6Pro CGM data included 45,645 data points following placement to upper arm. Additionally, average clinical measurements of day and overnight temperatures and hemodynamics were evaluated. Clinical and Dexcom data were restricted to being at least 1 hour after prior clinical reading Matching Dexcom G6Pro CGM data were required within 5 minutes of clinical measure. Data included only if taken at least 2 hours after Dexcom G6Pro CGM insertion (warm-up time) and and analyzed only following ICU admission. Finally, a dataset excluding the first 24 hours after ICU admission was created to explore stability of the device. Patients remained on Dexcom G6Pro CGM until discharge or 10 days postoperatively. Results The population was 71% male, 14% with known diabetes; 66% required IV insulin infusion. The Clarke error grid plot of all measures post-ICU admission showed 53.5% in Zone A, 45.9% in Zone B, and 0.6% (n=5) in Zones D or E. The restricted dataset that excluded the first 24 hours post-ICU admission showed 55.9% in Zone A, 43.9% in Zone B, and 0.2% in Zone D. Mean absolute relative difference (MARD) between clinical and Dexcom G6Pro CGM measures was 20.6% and 21.6% in the entire post-ICU admission dataset, and the dataset excluding the first 24 hours after ICU admission, respectively. In the sub-analysis of the 12 patients who did not have more than a 5-minute tap in the operating room, a Consensus error grid, demonstrated that after ICU admission, percentage in zone A was 53.9%, zone B 45.4%, and zone C 0.7%. Similar percentages were obtained removing the first 24 hours post-ICU admission. These numbers are very similar to the entire cohort. A consensus error grid created post-ICU admission demonstrated: (Zone A) 54%, (Zone B) 45%, (Zone C) 0.9%, and the following for the dataset created excluding the first 24 hours: (Zone A) 56%, (Zone B) 44%, (Zone C) 0.4%, which demonstrated very close agreement with the original Clarke error grid. No adverse events were reported. Conclusions Almost 100% of Dexcom G6Pro CGM and clinical data matching points fell within areas considered as giving clinically correct decisions (Zone A) and clinically uncritical decisions (Zone B). However, the relatively high MARD precludes its use for both monitoring and treatment in the clinical context. As technology evolves, interstitial glucose monitoring may become an important tool to limit iatrogenic anemia and mitigate glycemic fluctuations.

[Continuous Interstitial Subcutaneous Fluid Glucose (ISFG) Measurement during Pre- and Intraoperative Periods for Highly Invasive Surgery]

Continuous Glucose Monitoring Using the Dexcom G6 in Cardiac Surgery during the Postoperative Period.

Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit

The Efficacy of Intraoperatie Continuous Glucose Monitoring in Patients Undergoing Liver Transplantation: a Study Protocol for a Prospective Randomized Controlled Superiority Trial

Intraoperative intermittently scanned continuous glucose monitoring in the management of patients with pancreatic insulinoma

[Correlation Between the Amplitude of Glucose Excursion and Plasma 8-Iso Prostaglandin F2alpha Level in Subjects with Different Types of Glucose Regulation].

Preoperative Carbohydrate Loading with Individualized Supplemental Insulin in Diabetic Patients Undergoing Gastrointestinal Surgery: A Randomized Trial

Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation

Effects Of Preoperative Oral Carbohydrates On Patients Undergoing Esd Surgery Under General Anesthesia A Randomized Control Study

Preliminary Study on Glucose Control with an Artificial Pancreas in Postoperative Sepsis Patients

Clinical application of real‐time continuous glucose monitoring system during postoperative enteral nutrition therapy in esophageal cancer patients

Perioperative glycemic measures among non-fasting gynecologic oncology patients receiving carbohydrate loading in an enhanced recovery after surgery (ERAS) protocol

Impact of Different Crystalloids on the Blood Glucose Levels of Nondiabetic Patients Undergoing Major Elective Surgeries

Comparison of a continuous glucose-insulin-potassium infusion versus intermittent bolus application of insulin on perioperative glucose control and hormone status in insulin-treated type 2 diabetics

Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

Preoperative Carbohydrate Loading in Diabetic Patients Undergoing Gastrointestinal Surgery: A Pilot Randomized Trial

Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit

Evaluation of the effectiveness regarding the participation of pharmacists in perioperative blood glucose management via the iGMS: a pilot RCT

Preoperative fasting abbreviation (Enhanced Recovery After Surgery protocol) and effects on the metabolism of patients undergoing gynecological surgeries under spinal anesthesia: A randomized clinical trial

Effect of Intraoperative Glucose and Insulin Infusion on the Metabolism in Patients Undergoing Esophageal Cancer Surgery under Combined General Anesthesia with Epidural Block

Assisted Fluid Management and Sublingual Microvascular Flow During High-Risk Abdominal Surgery: A Randomized Controlled Trial